Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Urticaria | Treatment Algorithms: Claims Data Analysis | Chronic Inducible Urticaria | US | 2022
Chronic inducible urticaria (CIndU) encompasses various chronic urticaria subtypes caused by specific triggers. CIndU seems to be more resistant than chronic spontaneous urticaria (CSU) to standard…
Urticaria | Treatment Algorithms: Claims Data Analysis | Chronic spontaneous urticaria | US | 2022
The drug market for chronic spontaneous urticaria (CSU; previously known as chronic idiopathic urticaria) is dominated by oral medications, including those approved (e.g., first- and second-…
Urticaria | Treatment Algorithms: Claims Data Analysis | Chronic Inducible Urticaria | US | 2021
MARKET OUTLOOK Chronic inducible urticaria (CIndU) encompasses various chronic urticaria subtypes caused by specific triggers. CIndU appears to be more resistant than chronic spontaneous…
Urticaria | Treatment Algorithms: Claims Data Analysis | Chronic Spontaneous | US | 2021
The drug market for chronic spontaneous urticaria (CSU), previously know as chronic idiopathic urticaria, is dominated by oral medications, including first- and second-generation (nondrowsy)…
Urticaria | Treatment Algorithms: Claims Data Analysis | Chronic Inducible Urticaria | US | 2020
Chronic inducible urticaria (CIndU) encompasses various chronic urticaria subtypes caused by specific triggers. CIndU appears to be more resistant than chronic spontaneous urticaria (CSU) to…
Urticaria | Treatment Algorithms: Claims Data Analysis | Chronic Spontaneous | US | 2020
Chronic spontaneous urticaria (CSU), also known as chronic idiopathic urticaria, presents as hives that persist daily or almost daily for six weeks or longer without an obvious known stimulus. Drug…